Oxaliplatin

اگزالی‌پلاتین

⚠ Unverified

🎗️ Antineoplastic And Immunomodulating AgentsPlatinum compound

Market / country: 🇺🇸 USA

Eloxatin (US)

🧮 Dose calculator

Colorectal cancer · Regimen source: FDA Oxaliplatin · 2.1

  • • Concurrently with leucovorin 200 mg/m² (separate bag), then fluorouracil. Adjuvant up to 12 cycles. Prolong to 6 h for acute infusion reactions. FDA Oxaliplatin · 2.1FDA Oxaliplatin · 2.2
  • • Only under an oncologist in an equipped centre. Calculator = label mg/m² × BSA (Mosteller); protocol, cycle interval and adjustment for CBC and renal/hepatic function rest with the oncology team. FDA Oxaliplatin · 2.1

Enter age and weight.

🛡️ Safety & information

Contraindications

Warnings

  • • Boxed warning: serious and fatal hypersensitivity/anaphylaxis in any cycle — stop permanently. FDA Oxaliplatin · Boxed Warning
  • • Sensory neuropathy (cold-induced); severe myelosuppression; PRES; pulmonary and hepatic toxicity; QT; rhabdomyolysis; haemorrhage; embryo-fetal toxicity. FDA Oxaliplatin · 5

Renal adjustment

Formulations

👥 Special populations

  • 🤰 PregnancyDangerous / avoid

    Label: can cause fetal harm. Dangerous in pregnancy. FDA Oxaliplatin · 8.1

    “Risk Summary Based on its direct interaction with DNA, oxaliplatin can cause fetal harm when administered to a pregnant woman.”
  • 🤱 BreastfeedingDangerous / avoid

    Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Oxaliplatin · 8.2

    “Because of the potential for serious adverse reactions in breastfed infants, advise women not to breastfeed during treatment with oxaliplatin and for 3 months after the final dose.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Oxaliplatin · 8.4

    “The safety and effectiveness of oxaliplatin in pediatrics have not been established.”
  • 👴 Older adultsNo specific problem stated

    Label: no specific difference or dose adjustment stated for older adults. FDA Oxaliplatin · 8.5

    “No overall differences in effectiveness were observed between these patients and younger adults.”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Oxaliplatin · 8.3

    “Contraception Oxaliplatin can cause embryo-fetal harm when administered to a pregnant woman [see Use in Specific Populations (8.1) ] .”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav